Buy Unum Therapeutics Stock | UMRX Stock Price & Latest News | Public.com
UMRX

Unum Therapeutics

    Small Market Cap

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View Unum Therapeutics (UMRX) stock trends here

    About UMRX

    Cogent Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of precision therapies for genetically defined diseases. It focuses on CGT9486, a selective tyrosine kinase inhibitor that is designed to poten...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.17
    -0.34
    -0.52
    Q2 2021

    Expected EPS
    Q2 2021

    -$0.52

    Actual EPS
    Q2 2021

    Stats

    Market Cap$308,34M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$14.88
    1 Year Low$1.36
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app